Vaccine

Showing 15 posts of 283 posts found.

pfizer

Pfizer vaccine: Study finds increased breakthrough rates of South African variant

April 19, 2021
Sales and Marketing COVID-19, Pfizer, Vaccine, variant

A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …

Sanofi to invest €400 million on Singapore vaccine production site

April 12, 2021
Sales and Marketing Sanofi, Vaccine

Sanofi have today announced a €400 million investment to create a unique vaccine production centre in Singapore, in partnership with …

EMA launch investigation into J&J’s COVID-19 vaccine amid US blood clot reports

April 12, 2021
Sales and Marketing COVID-19, EMA, J&J, JJ, Vaccine

The EMA is reviewing reports of rare blood clots in four people in the US who received Johnson & Johnson’s …

astrazeneca_sign_sky

AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe

April 7, 2021
Research and Development AstraZeneca, COVID-19, Vaccine

AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …

gsk_boronia_australia

GSK to support manufacture of 60m Novavax COVID-19 vaccines

March 30, 2021
Manufacturing and Production COVID-19, GSK, UK, Vaccine

GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …

moderna_norwood_plant

500,000 Moderna COVID-19 vaccines to arrive in UK next month

March 29, 2021
Sales and Marketing COVID-19, Moderna, Vaccine

More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed. …

Novavax delays 100 million vaccines to the EU

March 26, 2021
Medical Communications COVID-19, EU, Vaccine

Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …

Pfizer's New York headquarters

Pfizer begins COVID-19 vaccine testing on young children

March 26, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer have begun testing its COVID-19 vaccine on children under the age of 12, with the trials’ first participants, a …

AstraZeneca sign

AstraZeneca vaccine found to be 3% less effective after further trial analysis

March 25, 2021
AstraZeneca, AstraZeneca vaccine, COVID-19, COVID-19 vaccine, Vaccine

AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms …

AstraZeneca and J&J COVID-19 vaccines face viral vector shortage

March 25, 2021
Astrazenaca, COVID-19, Johnson & Johnson, Vaccine

Both AstraZeneca and J&J face major manufacturing deficiencies for their recombinant vector COVID-19 vaccines, forcing competition over limited production capacity …

video_library01

Daiichi Sankyo begins trial for mRNA COVID-19 vaccine in Japan

March 22, 2021
Sales and Marketing COVID-19, Vaccine

Daiichi Sankyo, a global pharmaceutical company that provides services in 20 countries worldwide, has announced the first vaccinations as part …

RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine

March 19, 2021
Medical Communications COVID-19, Russia, Vaccine

The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …

AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA

March 19, 2021
Medical Communications AstraZeneca, COVID-19, EMA, Vaccine

AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …

Florida woman gives birth to first-known baby born with COVID-19 antibodies

March 18, 2021
COVID-19, Moderna, Vaccine

A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …

a vaccine is administered

Bharat Biotech’s COVAXIN jab 81% effective in Phase III trial

March 4, 2021
Bharat Biotech, COVID-19, COVID-19 vaccine, Vaccine, bharat

Bharat Biotech’s COVID-19 vaccine candidate has shown an interim efficacy of 81% in a Phase III trial, the company announced …

Latest content